索引超出了数组界限。
[1] Maron BJ,Ommen SR,Semsarian C,et al. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine [J]. J Am Coll Cardiol, 2014, 64(1): 83-99.
[2] Hensley N,Dietrich J,Nyhan D,et al. Hypertrophic cardiomyopathy: a review [J]. Anesth Analg, 2015, 120(3): 554-569.
[3] Maron BJ,Maron MS. Hypertrophic cardiomyopathy [J]. Lancet, 2013, 381(9862): 242-255.
[4] Elliott PM,Anastasakis A,Borger MA,et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2014, 35(39): 2733-2779.
[5] Jiang H,Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China [J]. Heart, 2009, 95(21): 1727-1731.
[6] Semsarian C,Ingles J,Maron MS,et al. New perspectives on the prevalence of hypertrophic cardiomyopathy [J]. J Am Coll Cardiol, 2015, 65(12): 1249-1254.
[7] 王颍骅,薛 松. 肥厚型梗阻性心肌病的外科治疗 [J]. 国际心血管病杂志, 2014, 41(5): 324-326.
[8] Gersh BJ,Maron BJ,Bonow RO,et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J]. J Thorac Cardiovasc Surg, 2011, 142(6): e153-203.
[9] Maron MS,Hauser TH,Dubrow E,et al. Right ventricular involvement in hypertrophic cardiomyopathy [J]. Am J Cardiol, 2007, 100(8): 1293-1298.
[10] Spirito P,Bellone P,Harris KM,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy [J]. N Engl J Med, 2000, 342(24): 1778-1785.
[11] Guo X,Fan C,Wang H,et al. The prevalence and long-term outcomes of extreme right versus extreme left ventricular hypertrophic cardiomyopathy [J]. Cardiology, 2016, 133(1): 35-43.
[12] Pantazis A,Vischer AS,Perez-Tome MC,et al. Diagnosis and management of hypertrophic cardiomyopathy [J]. Echo Res Pract, 2015, 2(1): R45-53.
[13] Walpot J,Pasteuning WH,Shivalkar B. Apical hypertrophic cardiomyopathy: elegant use of contrast-enhanced echocardiography in the diagnostic work-up [J]. Acta Cardiol, 2012, 67(4): 495-497.
[14] Parisi R,Mirabella F,Secco GG,et al. Multimodality imaging in apical hypertrophic cardiomyopathy [J]. World J Cardiol, 2014, 6(9): 916-923.
[15] Weissler-Snir A,Crean A,Rakowski H. The role of imaging in the diagnosis and management of hypertrophic cardiomyopathy [J]. Expert Rev Cardiovasc Ther, 2016, 14(1): 51-74.
[16] Patil PV,Wiegers SE. Echocardiography for hypertrophic cardiomyopathy [J]. Prog Cardiovasc Dis, 2014, 57(1): 91-99.
[17] Pandian NG,Rowin EJ,Gonzalez AM,et al. Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion [J]. Echo Res Pract, 2015, 2(1): E1-7.
[18] Williams LK,Gruner CH,Rakowski H. The role of echocardiography in hypertrophic cardiomyopathy [J]. Curr Cardiol Rep, 2015, 17(2): 560-566.
[19] Cavalcante JL,Barboza JS,Lever HM. Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy [J]. Prog Cardiovasc Dis, 2012, 54(6): 517-522.
[20] Kim DH,Handschumacher MD,Levine RA,et al. In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction [J]. Circulation, 2010, 122(13): 1298-1307.
[21] Joshi S,Patel UK,Yao SS,et al. Standing and exercise Doppler echocardiography in obstructive hypertrophic cardiomyopathy: the range of gradients with upright activity [J]. J Am Soc Echocardiogr, 2011, 24(1): 75-82.
[22] Peteiro J,Bouzas-Mosquera A,Fernandez X,et al. Prognostic value of exercise echocardiography in patients with hypertrophic cardiomyopathy [J]. J Am Soc Echocardiogr, 2012, 25(2): 182-189.
[23] Morise AP. Exercise testing in nonatherosclerotic heart disease: hypertrophic cardiomyopathy, valvular heart disease, and arrhythmias [J]. Circulation, 2011, 123(2): 216-225.
[24] Badran HM,Ibrahim WA,Faheem N,et al. Provocation of left ventricular outflow tract obstruction using nitrate inhalation in hypertrophic cardiomyopathy: Relation to electromechanical delay [J]. Glob Cardiol Sci Pract, 2015,(15): 11.
[25] Yalcin F,Yigit F,Erol T,et al. Effect of dobutamine stress on basal septal tissue dynamics in hypertensive patients with basal septal hypertrophy [J]. J Hum Hypertens, 2006, 20(8): 628-630.
[26] Roldan FJ,Vargas-Barron J,Espinola-Zavaleta N,et al. Severe dynamic obstruction of the left ventricular outflow tract induced by dobutamine [J]. Echocardiography, 2000, 17(1): 37-40.
[27] Harris KM,Spirito P,Maron MS,et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy [J]. Circulation, 2006, 114(3): 216-225.
[28] Weidemann F,Stork S,Liu D,et al. Cardiomyopathy of Friedreich ataxia [J]. J Neurochem, 2013, 126(S1): 88-93.
[29] Nagueh SF,Bierig SM,Budoff MJ,et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography [J]. J Am Soc Echocardiogr, 2011, 24(5): 473-498.
[30] Maciver DH. A new method for quantification of left ventricular systolic function using a corrected ejection fraction [J]. Eur J Echocardiogr, 2011, 12(3): 228-234.
[31] Smiseth OA,Torp H,Opdahl A,et al. Myocardial strain imaging: how useful is it in clinical decision making? [J]. Eur Heart J, 2015, 37(15): 1196-1207,
[32] Kalam K,Otahal P,Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction [J]. Heart, 2014, 100(21): 1673-1680.
[33] Haland TF,Almaas VM,Hasselberg NE,et al. Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6): 613-621,
[34] Nagueh SF,Appleton CP,Gillebert TC,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography [J]. J Am Soc Echocardiogr, 2009, 22(2): 107-133.
[35] Saito M,Okayama H,Yoshii T,et al. The differences in left ventricular torsional behavior between patients with hypertrophic cardiomyopathy and hypertensive heart disease [J]. Int J Cardiol, 2011, 150(3): 301-306.
[36] Shetty R,Samanth J,Nayak K,et al. Evaluation of subtle left ventricular systolic abnormalities in adult patients with hypertrophic cardiomyopathy [J]. J Clin Diagn Res, 2014, 8(12): MC05-09.